NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 167 filers reported holding NATERA INC in Q3 2019. The put-call ratio across all filers is 0.36 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $150,000 | -11.2% | 1,345 | -9.5% | 0.02% | 0.0% |
Q2 2021 | $169,000 | -26.8% | 1,486 | -34.7% | 0.02% | -23.1% |
Q1 2021 | $231,000 | -34.4% | 2,277 | -80.7% | 0.03% | -50.0% |
Q1 2020 | $352,000 | 0.0% | 11,805 | +13.1% | 0.05% | +26.8% |
Q4 2019 | $352,000 | +2.0% | 10,439 | -0.8% | 0.04% | +10.8% |
Q3 2019 | $345,000 | +222.4% | 10,523 | +172.1% | 0.04% | +236.4% |
Q2 2019 | $107,000 | +27.4% | 3,867 | -4.6% | 0.01% | -45.0% |
Q1 2019 | $84,000 | +33.3% | 4,054 | -9.8% | 0.02% | +33.3% |
Q4 2018 | $63,000 | -40.6% | 4,494 | +1.0% | 0.02% | -28.6% |
Q3 2018 | $106,000 | +14.0% | 4,448 | -9.9% | 0.02% | +10.5% |
Q2 2018 | $93,000 | +106.7% | 4,938 | +1.2% | 0.02% | +111.1% |
Q1 2018 | $45,000 | +2.3% | 4,878 | 0.0% | 0.01% | 0.0% |
Q4 2017 | $44,000 | -25.4% | 4,878 | +6.3% | 0.01% | -18.2% |
Q3 2017 | $59,000 | +34.1% | 4,590 | +12.8% | 0.01% | +37.5% |
Q2 2017 | $44,000 | +131.6% | 4,070 | +90.2% | 0.01% | +166.7% |
Q1 2017 | $19,000 | – | 2,140 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 881,436 | $48,937,327 | 32.36% |
Kynam Capital Management, LP | 2,918,237 | $162,020,518 | 20.92% |
Sofinnova Investments, Inc. | 3,100,560 | $172,143,091 | 11.01% |
Eversept Partners, LP | 2,819,770 | $156,553,630 | 10.92% |
Eagle Health Investments LP | 784,894 | $43,577,315 | 8.48% |
Lagoda Investment Management, L.P. | 162,625 | $9,028,940 | 6.42% |
BEACONLIGHT CAPITAL, LLC | 204,567 | $11,357,560 | 6.00% |
Bain Capital Life Sciences Investors, LLC | 700,197 | $38,875 | 4.86% |
PERKINS CAPITAL MANAGEMENT INC | 62,700 | $3,481 | 3.28% |
RTW INVESTMENTS, LP | 2,611,783 | $145,006,192 | 3.02% |